• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau 磷酸化在神经退行性疾病中的重要性。

The importance of tau phosphorylation for neurodegenerative diseases.

机构信息

Department of Neuroscience, King's College London, Institute of Psychiatry , London , UK.

出版信息

Front Neurol. 2013 Jul 1;4:83. doi: 10.3389/fneur.2013.00083. eCollection 2013.

DOI:10.3389/fneur.2013.00083
PMID:23847585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3696910/
Abstract

Fibrillar deposits of highly phosphorylated tau are a key pathological feature of several neurodegenerative tauopathies including Alzheimer's disease (AD) and some frontotemporal dementias. Increasing evidence suggests that the presence of these end-stage neurofibrillary lesions do not cause neuronal loss, but rather that alterations to soluble tau proteins induce neurodegeneration. In particular, aberrant tau phosphorylation is acknowledged to be a key disease process, influencing tau structure, distribution, and function in neurons. Although typically described as a cytosolic protein that associates with microtubules and regulates axonal transport, several additional functions of tau have recently been demonstrated, including roles in DNA stabilization, and synaptic function. Most recently, studies examining the trans-synaptic spread of tau pathology in disease models have suggested a potential role for extracellular tau in cell signaling pathways intrinsic to neurodegeneration. Here we review the evidence showing that tau phosphorylation plays a key role in neurodegenerative tauopathies. We also comment on the tractability of altering phosphorylation-dependent tau functions for therapeutic intervention in AD and related disorders.

摘要

高度磷酸化的 tau 纤维沉积是包括阿尔茨海默病(AD)和一些额颞叶痴呆在内的几种神经退行性 tau 病的主要病理特征。越来越多的证据表明,这些终末期神经纤维缠结并不会导致神经元丢失,而是可溶性 tau 蛋白的改变诱导了神经退行性变。特别是,tau 的异常磷酸化被认为是一个关键的疾病过程,影响 tau 在神经元中的结构、分布和功能。尽管 tau 通常被描述为一种与微管结合并调节轴突运输的细胞质蛋白,但最近已经证明了 tau 的几个其他功能,包括在 DNA 稳定和突触功能中的作用。最近,研究检查了疾病模型中 tau 病理学的跨突触传播,表明细胞外 tau 在神经退行性变中固有细胞信号通路中可能发挥作用。在这里,我们回顾了 tau 磷酸化在神经退行性 tau 病中起关键作用的证据。我们还评论了改变依赖磷酸化的 tau 功能以治疗 AD 和相关疾病的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eff/3696910/7dcfd0e6cb21/fneur-04-00083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eff/3696910/d1b9f4e0405c/fneur-04-00083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eff/3696910/7dcfd0e6cb21/fneur-04-00083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eff/3696910/d1b9f4e0405c/fneur-04-00083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eff/3696910/7dcfd0e6cb21/fneur-04-00083-g002.jpg

相似文献

1
The importance of tau phosphorylation for neurodegenerative diseases.tau 磷酸化在神经退行性疾病中的重要性。
Front Neurol. 2013 Jul 1;4:83. doi: 10.3389/fneur.2013.00083. eCollection 2013.
2
Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.内化的tau寡聚体通过诱导诱导多能干细胞来源的人类神经元中致病性tau的积累导致神经退行性变。
J Neurosci. 2015 Oct 21;35(42):14234-50. doi: 10.1523/JNEUROSCI.1523-15.2015.
3
The role of tau phosphorylation in the pathogenesis of Alzheimer's disease.tau蛋白磷酸化在阿尔茨海默病发病机制中的作用。
Curr Alzheimer Res. 2006 Dec;3(5):449-63. doi: 10.2174/156720506779025279.
4
Glial contributions to neurodegeneration in tauopathies.胶质细胞在tau蛋白病神经退行性变中的作用。
Mol Neurodegener. 2017 Jun 29;12(1):50. doi: 10.1186/s13024-017-0192-x.
5
Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.阿尔茨海默病和其他 Tau 病中的磷酸化 Tau。
Int J Mol Sci. 2022 Oct 25;23(21):12841. doi: 10.3390/ijms232112841.
6
Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.针对阿尔茨海默病和 tau 病的磷酸化 tau 靶向小分子 PROTACs。
Biochim Biophys Acta Mol Basis Dis. 2021 Aug 1;1867(8):166162. doi: 10.1016/j.bbadis.2021.166162. Epub 2021 Apr 30.
7
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.一种新型 TAO 激酶抑制剂可减少与神经退行性变相关的人 tau 病中 tau 磷酸化位点的磷酸化。
Acta Neuropathol Commun. 2018 May 7;6(1):37. doi: 10.1186/s40478-018-0539-8.
8
The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.病理性tau蛋白磷酸化与线粒体功能障碍之间的相互作用:理解和治疗阿尔茨海默病的关键
Mol Neurobiol. 2020 Dec;57(12):5103-5120. doi: 10.1007/s12035-020-02084-0. Epub 2020 Aug 26.
9
Intracellular and extracellular roles for tau in neurodegenerative disease.tau蛋白在神经退行性疾病中的细胞内和细胞外作用
J Alzheimers Dis. 2014;40 Suppl 1:S37-45. doi: 10.3233/JAD-132054.
10
Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders.Tau 在各种 Tau 病中的作用、治疗方法以及纳米技术在神经退行性疾病中的新作用。
Mol Neurobiol. 2023 Mar;60(3):1690-1720. doi: 10.1007/s12035-022-03164-z. Epub 2022 Dec 23.

引用本文的文献

1
New insights into the molecular biology of Alzheimer's-like cerebral amyloidosis achieved through multi-omics approaches.通过多组学方法对阿尔茨海默病样脑淀粉样变性分子生物学的新见解。
PLoS One. 2025 Sep 3;20(9):e0330859. doi: 10.1371/journal.pone.0330859. eCollection 2025.
2
Circ_0049472 downregulation relieves Amyloid-β-induced neuronal injury by modulating PDE4A expression via targeting miR-22-3p in Alzheimer's disease.在阿尔茨海默病中,Circ_0049472的下调通过靶向miR-22-3p调节PDE4A表达来减轻淀粉样β蛋白诱导的神经元损伤。
Metab Brain Dis. 2025 Aug 29;40(7):252. doi: 10.1007/s11011-025-01652-4.
3
From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape.

本文引用的文献

1
Tau phosphorylation affects its axonal transport and degradation.tau 磷酸化影响其轴突运输和降解。
Neurobiol Aging. 2013 Sep;34(9):2146-57. doi: 10.1016/j.neurobiolaging.2013.03.015. Epub 2013 Apr 17.
2
"Prion-like" templated misfolding in tauopathies.tau 病中的“类朊病毒样”模板化错误折叠。
Brain Pathol. 2013 May;23(3):342-9. doi: 10.1111/bpa.12044.
3
Prostate-derived sterile 20-like kinases (PSKs/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer disease.前列腺衍生的无菌 20 样激酶(PSKs/TAOKs)磷酸化 tau 蛋白,并在阿尔茨海默病的缠结神经元中被激活。
从更好的诊断到更早的治疗:快速演变的阿尔茨海默病格局
Medicina (Kaunas). 2025 Aug 14;61(8):1462. doi: 10.3390/medicina61081462.
4
Spectroscopic Profile of Metabolome Dynamics During Rat Cortical Neuronal Differentiation.大鼠皮质神经元分化过程中代谢组动力学的光谱特征
Int J Mol Sci. 2025 Aug 20;26(16):8027. doi: 10.3390/ijms26168027.
5
Cell-specific copper dyshomeostasis mechanism in Alzheimer's disease.阿尔茨海默病中细胞特异性铜稳态失衡机制
Transl Neurodegener. 2025 Aug 22;14(1):42. doi: 10.1186/s40035-025-00504-6.
6
From Acute Injury to Chronic Neurodegeneration: Molecular Mechanisms Linking Secondary Brain Injury to Long-Term Pathology.从急性损伤到慢性神经退行性变:连接继发性脑损伤与长期病理改变的分子机制
Int J Mol Sci. 2025 Jul 25;26(15):7191. doi: 10.3390/ijms26157191.
7
Neuroinflammation and nutrition in Alzheimer's disease.阿尔茨海默病中的神经炎症与营养
Front Neurol. 2025 Jul 23;16:1622571. doi: 10.3389/fneur.2025.1622571. eCollection 2025.
8
Stoichiometric 14-3-3ζ binding promotes phospho-Tau microtubule dissociation and reduces aggregation and condensation.化学计量的14-3-3ζ结合促进磷酸化 Tau 与微管解离,并减少聚集和凝聚。
Commun Biol. 2025 Jul 31;8(1):1139. doi: 10.1038/s42003-025-08548-0.
9
SORLA upregulation suppresses global pathological effects in aged tauopathy mouse brain.SORLA上调可抑制老年tau蛋白病小鼠大脑中的整体病理效应。
bioRxiv. 2025 Jun 29:2025.06.25.661599. doi: 10.1101/2025.06.25.661599.
10
Bioactive compound nanoparticles for Alzheimer's disease.用于阿尔茨海默病的生物活性化合物纳米颗粒
Inflammopharmacology. 2025 Jun 5. doi: 10.1007/s10787-025-01801-2.
J Biol Chem. 2013 May 24;288(21):15418-29. doi: 10.1074/jbc.M112.448183. Epub 2013 Apr 12.
4
The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.CAMKK2-AMPK 激酶通路通过 Tau 磷酸化介导 Aβ 寡聚物的突触毒性作用。
Neuron. 2013 Apr 10;78(1):94-108. doi: 10.1016/j.neuron.2013.02.003.
5
Why size matters - balancing mitochondrial dynamics in Alzheimer's disease.为什么大小很重要——在阿尔茨海默病中平衡线粒体动力学。
Trends Neurosci. 2013 Jun;36(6):325-35. doi: 10.1016/j.tins.2013.03.002. Epub 2013 Apr 11.
6
The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.阿尔茨海默病中谷氨酸能突触功能障碍和崩溃中淀粉样β和 tau 的交汇。
Ageing Res Rev. 2013 Jun;12(3):757-63. doi: 10.1016/j.arr.2013.03.002. Epub 2013 Mar 22.
7
Protein kinase inhibitors against malignant lymphoma.蛋白激酶抑制剂治疗恶性淋巴瘤。
Expert Opin Pharmacother. 2013 Apr;14(6):707-21. doi: 10.1517/14656566.2013.780031.
8
β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.β2 肾上腺素能受体、蛋白激酶 A(PKA)和 c-Jun N 端激酶(JNK)信号通路介导阿尔茨海默病模型中的 tau 病理。
J Biol Chem. 2013 Apr 12;288(15):10298-307. doi: 10.1074/jbc.M112.415141. Epub 2013 Feb 19.
9
Physiological release of endogenous tau is stimulated by neuronal activity.内源性 tau 的生理释放受神经元活动的刺激。
EMBO Rep. 2013 Apr;14(4):389-94. doi: 10.1038/embor.2013.15. Epub 2013 Feb 15.
10
Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.特异性抑制 p25/Cdk5 活性的 Cdk5 抑制肽可减少体内神经退行性变。
J Neurosci. 2013 Jan 2;33(1):334-43. doi: 10.1523/JNEUROSCI.3593-12.2013.